7[3]Kohorn EI, Goldstein DP, Hancock BW, et al. Combining the staging system of the international federation of gynecology and obstetrics with the scoring system of the world health organization for trophoblastic neoplasia. Report of the working committee of the international society for the study of trophoblastic disease and the international gynecologic cancer society. Int J Gynecol Cancer, 2000, 10:84 - 88
8[4]Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment. Int J Gynecol Cancer, 2001, 11:73-77
9[6]Newlands ES, Bagshawe KD, Begent RHJ, et al. Results with EMA/CO (etopside, methotrexate, actinomycin, cyclophosphamide and vincristine) regimen in high risk gestational trophoblastic tumours, 1970 to 1989.Br.J Obstet Gynecol, 1991, 98:550-557
10[7]Soper JT, Evans AC, Clarke- Pearson D, et al. Alternating weekly chemotherapy with etopside - methotrexate - dactinomycin/cyclophosphmide vincristine for high- risk gestational trophoblastic disease. Obstet Gynecol, 1994, 83: 113-117
